Morgan Stanley and JPMorgan have both maintained an overweight rating on Bajaj Finance after its March quarter results. The former predicts a target price of Rs 8,000 and the latter Rs 9,000, citing strong asset quality and growth potential. Goldman Sachs has suggested a buy rating on SBI Life Insurance, with a target price of Rs 1,510 due to the company’s robust visible new business growth. Choice Broking maintained an outperform rating on Maruti Suzuki with a target of Rs 10,331, due to the automobile manufacturer’s healthy Q4FY23 performance, high annual sales volume, and new launches.
AMFI Reshuffle: Five midcap stocks that may get upgraded to largecap
Nuvama Institutional Equities expects five midcap stocks, including Bosch, Zydus Lifesciences and Lodha Developers, to move into the largecap category in AMFI’s H1 CY27 reclassification.